Kamada Sets New 1-Year Low at $5.58 (KMDA)
Shares of Kamada (NASDAQ:KMDA) hit a new 52-week low during trading on Thursday , Analyst RN reports. The stock traded as low as $5.58 and last traded at $6.00, with a volume of 335,041 shares changing hands. The stock had previously closed at $7.16.
KMDA has been the subject of a number of recent research reports. Analysts at Zacks downgraded shares of Kamada from a “neutral” rating to an “underperform” rating in a research note on Thursday, August 7th. They now have a $6.60 price target on the stock. Analysts at Oppenheimer initiated coverage on shares of Kamada in a research note on Tuesday, July 8th. They set a “market perform” rating on the stock.
The stock’s 50-day moving average is $6.85 and its 200-day moving average is $10.79. The company’s market cap is $211.6 million.
Kamada (NASDAQ:KMDA) last issued its quarterly earnings data on Thursday, August 14th. The company reported ($0.23) EPS for the quarter, missing the Thomson Reuters consensus estimate of ($0.02) by $0.21. The company had revenue of $15.80 million for the quarter, compared to the consensus estimate of $17.17 million. On average, analysts predict that Kamada will post $-0.41 earnings per share for the current fiscal year.
Kamada Ltd. is an Israel-based biopharmaceutical company, which develops, produces and markets therapeutics, based on chromatographic purification technology.
Receive News & Ratings for Kamada Ltd Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kamada Ltd and related companies with Analyst Ratings Network's FREE daily email newsletter.